Serplulimab Antibody
Serplulimab (HLX10) is a humanized anti-PD-1 monoclonal antibody with demonstrated antitumor activity. It is applied in research for cancers like small cell lung cancer and esophageal squamous cell carcinoma, with studies supporting its use in both in vitro assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
HLX 10, HLX10, HLX-10, IFN-γ, Serplulimab
Target
PD-1/PD-L1, COX, STAT, Akt
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience, Signal Transduction, Stem Cell & Developmental Biology
Concentration
7.94 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.06 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6235230-01 0.1 mL
SENP7 (Sentrin-specific Protease 7, SUMO-1-specific Protease 2, Sentrin/SUMO-specific Protease SENP7, KIAA1707, SSP2, SUSP2) (MaxLight 750)
Sign In for Pricing
View Details MBS6235230-02 5x 0.1 mL
SENP7 (Sentrin-specific Protease 7, SUMO-1-specific Protease 2, Sentrin/SUMO-specific Protease SENP7, KIAA1707, SSP2, SUSP2) (MaxLight 750)
Sign In for Pricing
View Details 032997-ML750 100 µL
C4orf49, CT (MGARP, C4orf49, CESP1, HUMMR, OSAP, Protein MGARP, Corneal endothelium-specific protein 1, Hypoxia up-regulated mitochondrial movement regulator protein, Mitochondria-localized glutamic acid-rich protein, Ovary-specific acidic protein) (MaxLight 750) discontinued
Sign In for Pricing
View Details